Cited by 18Pregnancy and preeclampsia studiesNeurological Complications and SyndromesReproductive System and Pregnancy

Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia

MALSHE, AMOL K., SIBAI, BAHA M.·2017·Clinical Obstetrics & Gynecology

Abstract

Preeclampsia is a pregnancy-specific hypertensive disorder with multisystem involvement and is a significant cause of obstetric morbidity and mortality worldwide. A major issue in the treatment of preeclampsia stems from its still significant rates of misclassification and misdiagnosis. Angiogenic factors have been speculated as a possible diagnostic modality due to a perceived imbalance in angiogenesis in preeclampsia. Factors currently studied include soluble fms-like protein kinase 1 and placental growth factor. Because of significant mortality associated with preeclampsia it is felt that both early and accurate diagnosis of preeclampsia is imperative if this disease process is to be treated.

Integrity signals

Registry

Crossref · 10.1097/grf.0000000000000267

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
MALSHE, A. K., & SIBAI, B. M.
Affiliations
The University of Texas Health Science Center at Houston (US)
Venue
Clinical Obstetrics & Gynecology
Published
2017-03
Volume
60
Issue
1
Pages
134-140
ISSN
0009-9201 (ISSN-L)
OpenAlex
W2568775363
Cited by
18
References
38
Citations by year
2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 4
FWCI
3.54
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Obstetrics & Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
preeclampsia, angiogenic biomarkers, soluble fms-like tyrosine kinase-1, placental growth factor, risk classification, preeclampsia diagnosis, hypertensive disorders of pregnancy
MeSH terms
Placenta Growth Factor, Female, Humans, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Proteins, Biomarkers, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Receptor-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review